<DOC>
	<DOCNO>NCT02064868</DOCNO>
	<brief_summary>This multinational , multicenter , randomize , open-label study confirm expand efficacy , safety tolerability evidence 48 hour intravenous infusion serelaxin ( 30 micrograms/kg/day ) add Standard Care ( SoC ) patient admit hospital Acute Heart Failure ( AHF ) .</brief_summary>
	<brief_title>Effect Serelaxin Versus Standard Care Acute Heart Failure ( AHF ) Patients</brief_title>
	<detailed_description>This study aim generate clinical evidence , especially short term period ( in-hospital 30 day ) complement exist future serelaxin data set Acute Heart Failure ( AHF ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Mineralocorticoid Receptor Antagonists</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Systolic blood pressure &gt; 125 mmHg Admitted Acute Heart Failure ( AHF ) Received intravenous furosemide ( equivalent ) time presentation start screen eGFR admission : ≥ 25 ≤75 mL/min/1.73 m^2 Dyspnea ( noncardiac cause ) T &gt; 38.5°C Clinical evidence acute coronary syndrome currently within 30 day prior enrollment . Significant leave ventricular outflow obstruction , uncorrected , obstructive hypertrophic cardiomyopathy severe aortic stenosis ( i.e. , aortic valve area &lt; 1.0 cm^2 mean gradient &gt; 50 mmHg prior current echocardiogram ) , severe aortic regurgitation severe mitral stenosis . AHF due significant arrhythmias Acute myocarditis hypertrophic obstructive , restrictive , constrictive cardiomyopathy ( include restrictive mitral filling pattern see Doppler echocardiographic assessment diastolic function ) . Other protocol define inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>AHF ,</keyword>
	<keyword>RLX030 ,</keyword>
	<keyword>SOC ,</keyword>
	<keyword>WHF ,</keyword>
	<keyword>RELAX-AHF-EU</keyword>
	<keyword>Renal Impairment</keyword>
</DOC>